 Senator Bernie Sanders is optimistic Novo Nordics can be convinced to lower the price of Ozempic and Wegovy by publicly shaming the company over how it charges in the U.S. versus other countries. Silvana now has the story. The CEO of the Danish drug maker is set to testify before a Senate committee chaired by Sanders in September. Sanders tells Reuters he wants Novo to reduce the price of Ozempic to about $155, which is what it costs in Canada.